Trials / Completed
CompletedNCT02673411
Ultrasonography SWE for Hepatic Fibrosis Evaluation
Diagnostic Performance of Shear Wave Elastography for Fibrosis Evaluation: Preliminary Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 140 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to measure diagnostic performance of ultrasound shear wave elastography to detect advanced hepatic fibrosis.
Detailed description
Hepatic fibrosis causes liver dysfunction and HCC. Since hepatic fibrosis is reversible dynamic condition, its monitoring is important to predict long term outcome and to determine treatment plan. The reference of standard to diagnose hepatic fibrosis is biopsy, but recently non-invasive method such as stiffness imaging has been drawing a lot of attention. In this study, ultrasound shear wave elastography will be performed and its diagnostic performance to detect advanced hepatic fibrosis (= \> F2) will be measured using histologic grade as a reference.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ultrasound shear wave elastography | ultrasound shear wave elastography is performed in GE ultrasound scanner according to guidelines of ultrasound elastography. |
Timeline
- Start date
- 2016-03-03
- Primary completion
- 2016-09-27
- Completion
- 2017-01-16
- First posted
- 2016-02-03
- Last updated
- 2021-03-17
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02673411. Inclusion in this directory is not an endorsement.